Alerts will be sent to your verified email
Verify EmailACCPL
Accretion Pharma. balance sheet is weak and might have solvency issues
Yes, The debt of Accretion Pharma. is increasing.
Latest debt of Accretion Pharma. is ₹0 Crs as of latest yr.
This is greater than previous yr when it was ₹0 Crs.
The profit is oscillating.
The profit of Accretion Pharma. is ₹3.88 Crs for Mar 2024, ₹0 Crs for Mar 2024 and ₹0 Crs for Mar 2023
The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Accretion Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
NA